Shin Nippon Biomedical Laboratories, Ltd.
Symbol: 2395.T
JPX
1392
JPYMarktpreis heute
10.3343
P/E-Verhältnis
-0.0844
PEG-Verhältnis
57.95B
MRK Kapital
- 0.04%
DIV Rendite
Shin Nippon Biomedical Laboratories, Ltd. (2395-T) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 10533.1 | 6997 | 7286.5 | |||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | -423.6 | 368.1 | 55.8 | |||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 4760.4 | 3501.6 | 2954.1 | |||||||||||||||||||
balance-sheet.row.inventory | 0 | 7329.4 | 4359.4 | 4071.4 | |||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 1276.7 | 1276.5 | 468.1 | |||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 23899.6 | 16134.5 | 14780 | |||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 18879.3 | 13155.8 | 12898 | |||||||||||||||||||
balance-sheet.row.goodwill | 0 | 1438.8 | 0.3 | 0.8 | |||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 260.7 | 212 | 213 | |||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1699.4 | 212.3 | 213.8 | |||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 12404 | 8645 | 8522 | |||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 325.8 | 1129.6 | 521.6 | |||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 34.2 | 35.4 | 37 | |||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 33342.6 | 23178.2 | 22192.4 | |||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-assets | 0 | 57242.2 | 39312.7 | 36972.4 | |||||||||||||||||||
balance-sheet.row.account-payables | 0 | 419.8 | 64.6 | 95 | |||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 8923.2 | 2942.7 | 3486.8 | |||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 603.7 | 743.1 | 683.2 | |||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 9837.5 | 6195.6 | 9199.2 | |||||||||||||||||||
Deferred Revenue Non Current | 0 | -1064 | -68.2 | -642.4 | |||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 3009.8 | 2685.1 | 2317.4 | |||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 9871.5 | 6215.6 | 9217.8 | |||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 357 | 385.8 | 529.3 | |||||||||||||||||||
balance-sheet.row.total-liab | 0 | 30883.2 | 19589.5 | 21133.6 | |||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 2620.8 | 105.7 | |||||||||||||||||||
balance-sheet.row.common-stock | 0 | 9679.1 | 9679.1 | 9679.1 | |||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 13766.2 | 10196.3 | 3854.5 | |||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 460.2 | -2620.8 | -105.7 | |||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2306.4 | -314.3 | 2200.9 | |||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 26211.8 | 19561.1 | 15734.5 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 57242.2 | 39312.7 | 36972.4 | |||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 147.2 | 162 | 104.3 | |||||||||||||||||||
balance-sheet.row.total-equity | 0 | 26359 | 19723.1 | 15838.8 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||
Total Investments | 0 | 11980.4 | 7080.1 | 8286.9 | |||||||||||||||||||
balance-sheet.row.total-debt | 0 | 18760.7 | 9138.3 | 12686.1 | |||||||||||||||||||
balance-sheet.row.net-debt | 0 | 8227.6 | 2509.4 | 5455.3 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 7759.6 | 8183.3 | 4175.6 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1600.5 | 1177.4 | 1187.7 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -2812.9 | 723.3 | 532 | |||||||||||||||||||
cash-flows.row.account-receivables | 0 | -937 | -480 | -343 | |||||||||||||||||||
cash-flows.row.inventory | 0 | -968.5 | -371.1 | -71.7 | |||||||||||||||||||
cash-flows.row.account-payables | 0 | -268.2 | -36.7 | -24.2 | |||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -639.2 | 1611.1 | 970.8 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -2543.2 | -4131.3 | -1148.5 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -4955.7 | -1614.3 | -1118 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -1937.2 | 1200.8 | 1242.3 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -1514.3 | -4194.1 | -895 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 2532.2 | 266.7 | 91.4 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | -55.5 | 72.3 | 410.6 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -5930.6 | -4268.5 | -268.7 | |||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -5468.1 | -3492.3 | -4598.2 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0.2 | 0 | 0 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -0.2 | 0 | 0 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -2484.4 | -826.5 | -206.2 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 14218.8 | -593.1 | 2333.4 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 6266.2 | -4912 | -2471.1 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 311.5 | 496.7 | 29.6 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 4648.9 | -2731 | 2036.6 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 9197.7 | 4548.8 | 7279.8 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 4548.8 | 7279.8 | 5243.3 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 4004 | 5952.8 | 4746.7 | |||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -4955.7 | -1614.3 | -1118 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -951.7 | 4338.5 | 3628.7 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 25090.9 | 17748.5 | 15110.5 | |||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 12044.2 | 8061.2 | 7556.1 | |||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 13046.7 | 9687.3 | 7554.4 | |||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 15.2 | 191.1 | 211.4 | |||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 7801.4 | 5491.7 | 5024.9 | |||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 19845.7 | 13552.9 | 12581 | |||||||||||||||||||
income-statement-row.row.interest-income | 0 | 57.4 | 8.3 | 3 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 125.1 | 126.6 | 184.9 | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 2514 | 3986 | 1644 | |||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 15.2 | 191.1 | 211.4 | |||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 2514 | 3986 | 1644 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 125.1 | 126.6 | 184.9 | |||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1600.5 | 1177.4 | 1187.7 | |||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.operating-income | 0 | 5245.2 | 4195.6 | 2529.5 | |||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 7759.6 | 8183.3 | 4175.6 | |||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 1708.9 | 1016.2 | 497.8 | |||||||||||||||||||
income-statement-row.row.net-income | 0 | 6060.1 | 7127.6 | 3661.9 |
Häufig gestellte Frage
Wie hoch ist die Shin Nippon Biomedical Laboratories, Ltd. (2395.T) Gesamtvermögen?
Shin Nippon Biomedical Laboratories, Ltd. (2395.T) Gesamtvermögen ist 57242205000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.522.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist 85.787.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist 0.206.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.150.
Was ist der Shin Nippon Biomedical Laboratories, Ltd. (2395.T) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist 6060057000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 18760662000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 7801426000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 0.000.